Krystal Biotech: Investment Thesis Confirmed - The Platform Proof has been Established

In my previous analyses for the Trader Journal and the GROWTH magazine, I have already highlighted Krystal Biotech (KRYS) in detail. At that time, the focus was on the transformation from a research company to a profitable biotech player through the world's first topical gene therapy. Anyone who wants to read the fundamental derivation and business model again can find the deep dives here: Analyse 1: With a Gel Tube into the Future of Gene Therapy   Analyse 2: The Rise to a Profitable Giant   However, the events of the first...